glp-1 agonist dementia Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment Comparative dementia risk with GLP1
Description
Specifically, the effect of body weight was partially recovered by 2852 weeks, and became less significant again after 1 year
8 Therefore, given the increasing burden of lean MASLD in some populations and the benefits of GLP-1RA in weight management, more clinical attention is warranted
This confirmed the glucagon receptor as the primary driver of the direct cardiac effects
Can you talk about what those were and what you learned
The waitlist is free, with no commitment and no payment details required
doi: 10.1210/en.2009-1197
